NeoSoul

NeoSoul, ticker DNA, is classified as an other digital asset, meaning it does not fit neatly into the standard categories of a layer-one blockchain or a decentralised-finance protocol. The project description stored for this asset is empty, so the specific problem it claims to address and the audience it targets cannot be stated with certainty from the available data alone. What is recorded is that it trades under the DNA symbol with a circulating supply of 130,000,000 tokens and a market capitalisation of approximately 36.7 million US dollars at the current price of 0.28228 USD.

No consensus algorithm, block time, or on-chain settlement detail is stored for NeoSoul, so a precise mechanical description of how the network reaches agreement or finalises transactions cannot be given. The token's role within whatever system it belongs to — whether governance, utility, or something else — is likewise absent from the data. What is known is that DNA exists as a circulating digital token; beyond that, the technical architecture is not documented here.

No fee stream, revenue mechanism, or protocol-level economics are recorded for NeoSoul in the data held on this site. That means fee-based measures such as protocol revenue, fee yields, or earnings multiples that appear elsewhere on this site have no foundation to be calculated for DNA and should be treated as absent rather than zero by default. The supply figures are point-in-time snapshots: 130,000,000 tokens are in circulation, representing 13 percent of the 1,000,000,000 maximum supply, leaving 870,000,000 tokens not yet issued.